Search All News
A new study offers evidence that replacing 30 minutes of sitting with physical activity, of any intensity or amount, reduces the risk of early death.
A new study in Amish people suggests that reducing the activity of a protein that regulates plasma triglycerides could prevent cardiovascular disease.
A study led by Columbia researchers found that a minimally invasive technique to repair the mitral valve improved two-year survival for certain heart failure patients.
A new study led by Columbia's Mathew Maurer found that tafamidis reduced deaths from transthyretin amyloid cardiomyopathy, a type of heart failure.
- April 2, 2016
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.
- February 24, 2016
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a new study from Columbia researchers.
- January 6, 2016
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
- December 9, 2015
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
- December 7, 2015
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.
Source:Washington PostSeptember 14, 2015
- August 31, 2015
An analysis documents worse outcomes and burgeoning costs for patients with diabetes who have coronary artery disease that requires surgery.
- August 13, 2015
Columbia researcher Jon Giles has published research showing a link between atherosclerosis and depressive symptoms, stress, anxiety, anger, and lack of social support in patients with rheumatoid arthritis.
- August 4, 2015
Columbia research shows that expanding treatment of high blood pressure with cost-effective medication could prevent 1 million heart attacks and strokes in China.